Upexi, Inc
Upexi, Inc is a personal products company that offers a range of consumer goods within the personal care segment, generating revenue primarily through the sale of these products to consumers.
Business. Upexi, Inc. (UPXI.O) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in the United States and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsFY 2026 earnings (expected)2026-08-09 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Upexi, Inc. (UPXI.O) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in the United States and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Upexi, Inc has a market capitalization of $106.04 million and a price-to-book ratio of 4.81, indicating that the market is valuing the company at a premium to its book value. The company's liquidity position is characterized by a current ratio of 0.7, suggesting that it has less current assets than current liabilities, which could pose a liquidity risk. The debt-to-equity ratio of 1.21 indicates that the company is financed by a combination of debt and equity, with a slight tilt towards debt.
In terms of profitability, Upexi, Inc reported a net loss of $4.12 million and an operating loss of $5.04 million, which is significantly below the industry median for profitability metrics. The return on equity of -18.67% and return on assets of -7.29% further underscore the company's unprofitable operations. These figures suggest that the company is not generating returns that meet the expectations of its shareholders or asset base.
The company's revenue is concentrated in a single business segment, as there are no disclosed segments, and there is no information on geographic exposure. This lack of diversification could expose the company to higher risk if the personal products market experiences a downturn.
The growth trajectory of Upexi, Inc is not clearly defined, as there is no outlook data provided for the current or next fiscal year. The company's operating cash flow is negative at -$2.82 million, and its free cash flow is also negative at -$1.96 million, indicating that the company is not generating sufficient cash from operations to fund its activities.
The risk assessment for Upexi, Inc highlights a medium liquidity risk and a low dilution risk. The company's capital structure includes a significant amount of long-term debt, which could lead to financial distress if the company is unable to meet its debt obligations. The risk of dilution is low, as there is no indication of a large number of shares outstanding or a potential for a significant increase in shares.
Recent events related to Upexi, Inc include analyst estimates that suggest a wide range of price targets, from $2.00 to $8.00, with a mean and median price target of $5.00. The mean recommendation from analysts is 2.00, which is a "Buy" rating, indicating that analysts are generally optimistic about the company's future performance.
- Upexi, Inc is currently unprofitable, with a net loss and operating loss, and a negative return on equity and assets.
- The company's liquidity position is weak, as indicated by a current ratio of 0.7 and a negative operating cash flow.
- The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.21.
- Analysts have a generally positive outlook on the company, with a mean recommendation of "Buy" and a mean price target of $5.00.
- margin_outlook_rationale: The company's margin outlook is negative due to its unprofitable operations and negative return on equity and assets.
- rd_outlook_rationale: There is no information provided on the company's research and development activities or outlook.
- capex_outlook_rationale: The company's capital expenditure is negative, indicating a reduction in investment in long-term assets.
Bull / Bear case
Generated · model-assistedAnalysts project 488% upside to a $5.00 mean price target, signaling strong potential for significant share price appreciation.
The company maintains a current ratio of 1.74, indicating sufficient short-term liquidity to cover immediate operational obligations.
Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder equity value from share issuance.
Debt-to-equity ratio of 1.21 is in the bottom quartile, signaling excessive leverage compared to the 0.13 peer median.
Interest coverage of -120.4 indicates the company cannot cover interest expenses with operating income, raising significant solvency concerns.
In focus — financials by report
Revenue $8.1M, +101,0% YoY; Operating income −16 240,4% YoY.
- ▍Revenue $8.1M, +101,0% YoY
- ▍Operating income −16 240,4% YoY
- ▍Net income −13 649,6% YoY
- ▍Free cash flow −20 225,2% YoY
- ▍Net margin -2222.1%
Revenue $9.2M, +112,1% YoY; Operating income +5 279,6% YoY.
- ▍Revenue $9.2M, +112,1% YoY
- ▍Operating income +5 279,6% YoY
- ▍Net income +4 206,1% YoY
- ▍Free cash flow +4 460,7% YoY
- ▍Net margin 722.4%
Revenue $4.3M, +112,8% YoY; Operating income +54,2% YoY.
- ▍Revenue $4.3M, +112,8% YoY
- ▍Operating income +54,2% YoY
- ▍Net income +56,0% YoY
- ▍Free cash flow +58,3% YoY
- ▍Net margin -161.5%
Revenue $5.2M; Operating income -$5.0M.
- ▍Revenue $5.2M
- ▍Operating income -$5.0M
- ▍Net margin -78.9%
Revenue $15.8M, −39,2% YoY; Operating income +44,4% YoY.
- ▍Revenue $15.8M, −39,2% YoY
- ▍Operating income +44,4% YoY
- ▍Net income +42,2% YoY
- ▍Free cash flow +40,9% YoY
- ▍Net margin -86.5%
Revenue $26.0M, −28,6% YoY; Operating income −82,9% YoY.
- ▍Revenue $26.0M, −28,6% YoY
- ▍Operating income −82,9% YoY
- ▍Net income −39,7% YoY
- ▍Free cash flow −98,2% YoY
- ▍Net margin -91.0%
Revenue $36.4M, +58,0% YoY; Operating income −98,5% YoY.
- ▍Revenue $36.4M, +58,0% YoY
- ▍Operating income −98,5% YoY
- ▍Net income −705,9% YoY
- ▍Free cash flow −16,3% YoY
- ▍Net margin -46.5%
Revenue $23.1M, −4,3% YoY; Operating income −379,0% YoY.
- ▍Revenue $23.1M, −4,3% YoY
- ▍Operating income −379,0% YoY
- ▍Net income −170,5% YoY
- ▍Free cash flow −485,0% YoY
- ▍Net margin -9.1%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -1,94 |
| Revenue | —no estimate | —no estimate | 29,8M USD |
| Operating income | —no estimate | —no estimate | -127,3M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Upexi, Inc Market data — financials · 2026-05-29
- Upexi, Inc Market data — analyst estimates · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2025-12-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Allan MarshallChairman of the Board, Chief Executive Officer
Insider activity
- Director, Chief Executive Officer · Common StockBought 50 000 @ $1,80$90K · 2025-12-23
- Director, Chief Executive Officer · Common StockBought 50 000 @ $2,07$104K · 2025-12-16
- Director, Chief Executive Officer · Common StockBought 100 000 @ $2,07$207K · 2025-12-15
- Director · Common StockBought 50 000 @ $2,55$128K · 2025-11-20
- Director · Common StockBought 100 000 @ $2,81$281K · 2025-11-17
- Director · Common StockBought 100 000 @ $2,65$265K · 2025-11-17
- Director, Chief Executive Officer · Common StockOther 1 600 000 · 2025-10-01
- Director, Chief Financial Officer · Common StockOther 240 000 · 2025-10-01
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Current ratio (FY 2025-12-31): 2.20xDerived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 1,446.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 1,194.7%Derived (calculated)
- Current liabilities (annual): USD 77.85MSEC XBRL filing
- Shares outstanding (annual): 63.21MSEC XBRL filing
- Total assets (annual): USD 271.14MSEC XBRL filing
- Shareholders' equity (annual): USD 48.72MSEC XBRL filing
- Current assets (annual): USD 171.25MSEC XBRL filing
- Net margin (FY 2025-06-30): -86.5%Derived (calculated)
- Revenue (YoY) (2025-06-30 vs 2024-06-30): -39.2%Derived (calculated)
- Operating income (YoY) (2025-06-30 vs 2024-06-30): 44.4%Derived (calculated)
- Gross margin (FY 2025-06-30): 68.7%Derived (calculated)
- Operating cash flow (YoY) (2025-06-30 vs 2024-06-30): -8,208.7%Derived (calculated)
- EPS (basic) (YoY) (2025-06-30 vs 2024-06-30): 92.5%Derived (calculated)
- EPS (diluted) (YoY) (2025-06-30 vs 2024-06-30): 92.5%Derived (calculated)
- Capex (YoY) (2025-06-30 vs 2024-06-30): -58.4%Derived (calculated)
- Gross profit (YoY) (2025-06-30 vs 2024-06-30): -15.3%Derived (calculated)
- Net income (YoY) (2025-06-30 vs 2024-06-30): 42.2%Derived (calculated)
- Cost of revenue (YoY) (2025-06-30 vs 2024-06-30): -62.5%Derived (calculated)
- Operating cash flow (annual): USD -8.42MSEC XBRL filing
- Cost of revenue (annual): USD 4.94MSEC XBRL filing
- Interest expense (annual): USD 103.81KSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -2SEC XBRL filing
- Pre-tax income (annual): USD -13.68MSEC XBRL filing